New therapy for HER2-positive breast cancer developed
Tuesday, July 26, 2011 - 12:30
in Health & Medicine
Patients with HER2-positive breast cancer may soon have an alternative therapy when they develop resistance to trastuzumab, also known as Herceptin, according to a laboratory finding published in Clinical Cancer Research.